Abviris is a pioneer in HPV serology, developing innovative, next generation, products such as Prevo-Check® for early detection and post-treatment monitoring of HPV-induced tumors. Prevo-Check® makes it possible to easily detect precancerous lesions from a drop of blood, thereby helping patients to improve their quality of life and chances of survival.
NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: FOR IMMEDIATE RELEASE Abviris attracts almost 2M Euros […]
Weiterlesen »NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: FOR IMMEDIATE RELEASE ‘Pinprick’ biomarker blood test offers diagnostic […]
Weiterlesen »Abviris Deutschland GmbH has been awarded “Pilot of the Year“ by the UK Diagnostics Summit 2019. This prestigious award was presented at the summit on 28 November 2019 in Manchester. […]
Weiterlesen »You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information